Transition From Heparin to Citrate Anticoagulation for Continuous Renal Replacement Therapy: Safety, Efficiency, and Cost

Therapeutic Apheresis and Dialysis

Volumn 20, Issue 1, 2016, Pages 53-59

  Gutierrez Bernays, David ^a   Ostwald, Matthew ^a   Anstey, Chris ^a,b   Campbell, Victoria ^a,b  

^a SUNSHINE COAST HOSPITAL AND HEALTH SERVICE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Anticoagulation; Citrate; Continuous renal replacement therapy; Dialysis

Indexed keywords

CITRIC ACID; HEPARIN; ANTICOAGULANT AGENT; CALCIUM CHELATING AGENT;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DIALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; AGED; AUSTRALIA; CHEMICALLY INDUCED; COST; DRUG ADMINISTRATION ROUTE; ECONOMICS; HEMORRHAGE; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; AUSTRALIA; CALCIUM CHELATING AGENTS; CITRIC ACID; COSTS AND COST ANALYSIS; DRUG ADMINISTRATION ROUTES; FEMALE; HEMORRHAGE; HEPARIN; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES;

EID: 84958617057     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12331     Document Type: Article

References (16)

1. Oudemans-van Straaten HM, Ostermann M. Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice. Crit Care 2012;16:249.
2. Davenport A. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. Am J Kidney Dis 1997;30:20-7.
3. Fealy N, Baldwin I, Bellomo R, Baldwin I, Bellomo, R. The effect of circuit "down-time" on uraemic control during continuous venovenous hemofiltration. Crit Care Resusc 2002;4:266-70.
4. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990;38:976.
5. Morita Y, Johnson RW, Dorn RE, Hall DS. Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 1961;242:32-43.
6. Wu MY, Hsu YH, Bai CH, Wu CH, Tam KW. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2012 Jun;59:810-8.
7. Mehran M, Berghmans D, Ledooux D, Canivet J, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004;30:260-5.
8. Schilder L, Nurmohamed SA, Bosch FH et al. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial. Crit Care 2014;18:472.
9. Oudemans-van Straaten HM, Bosman RJ, Koopmans M et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009;37:545-52.
10. Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing renal replacement therapy. Intensive Care Med 2012 Jan;38:20-8.
11. Kramer L, Bauer E, Joukhadar C. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003;31:2450-5.
12. Tolwani AJ, Campbell RC, Schenk MB. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001;60:370-4.
13. Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clin Pract 2012;120:179-84.
14. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001;29:748-52.
15. Neligan PJ, Deutschman CS. Perioperative Acid-base Balance. In: Miller RD, ed. Miller's Anaesthesia, 7th edn. Philadelphia: Churchill Livingstone, 2005;1557-72.
16. Van De Wetering J, Westendorp RGJ, Van Der Hoeven JG. Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996;7:145-50.